From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties
Compound
∆G and binding affinity (Kcal/mol)
7e
 − 10.3
STU299
 − 11.5